Detalhe da pesquisa
1.
Designing peptide amphiphiles as novel antibacterials and antibiotic adjuvants against gram-negative bacteria.
Bioorg Med Chem
; 94: 117481, 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776750
2.
Helminth products modulate innate immune recognition of nucleic acids in systemic lupus erythematosus.
Lupus
; 31(4): 415-423, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202548
3.
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
J Virol
; 93(8)2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700598
4.
cAIMP administration in humanized mice induces a chimerization-level-dependent STING response.
Immunology
; 157(2): 163-172, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919991
5.
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.
Clin Infect Dis
; 64(12): 1686-1695, 2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329286
6.
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
J Virol
; 90(9): 4441-4453, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26889036
7.
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
PLoS Pathog
; 11(9): e1005142, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26379282
8.
Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research.
J Transl Med
; 14: 44, 2016 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26861779
9.
Targeted cytotoxic therapy kills persisting HIV infected cells during ART.
PLoS Pathog
; 10(1): e1003872, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415939
10.
Histone deacetylase inhibitor romidepsin inhibits de novo HIV-1 infections.
Antimicrob Agents Chemother
; 59(7): 3984-94, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25896701
11.
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.
Mediators Inflamm
; 2015: 120605, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26696749
12.
Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice.
PLoS Pathog
; 8(6): e1002732, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22737068
13.
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1.
J Exp Med
; 204(4): 705-14, 2007 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-17389241
14.
In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis.
Retrovirology
; 10: 125, 2013 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24172637
15.
Generation of HIV latency in humanized BLT mice.
J Virol
; 86(1): 630-4, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22013053
16.
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.
Nat Med
; 12(11): 1316-22, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17057712
17.
Development and implementation of natural killer cell simultaneous ADCC and direct killing assay.
Heliyon
; 9(12): e22991, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125417
18.
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.
Nat Med
; 29(10): 2547-2558, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696935
19.
Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.
Retrovirology
; 9: 44, 2012 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22640559
20.
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates.
J Virol
; 85(15): 7582-93, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21593172